Literature DB >> 1346700

Inhibition of NO synthesis in septic shock.

R S Hotchkiss, I E Karl, J L Parker, H R Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1346700     DOI： 10.1016/0140-6736(92)90127-o

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  The cytokine response to critical illness.

Authors:  B A Foëx; M P Shelly
Journal:  J Accid Emerg Med       Date:  1996-05

Review 2.  Intensive care.

Authors:  S Sinclair; M Singer
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

3.  Dimethylarginines in chronic renal failure.

Authors:  N Wahbi; R N Dalton; C Turner; M Denton; I Abbs; R Swaminathan
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

Review 4.  Septic shock: pathogenesis and treatment.

Authors:  L Castillo; M Sanchez
Journal:  Indian J Pediatr       Date:  1993 May-Jun       Impact factor: 1.967

5.  A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.

Authors:  J Schilling; M Cakmakci; U Bättig; S Geroulanos
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

6.  Comparison of the ability of nicardipine, theophylline and zaprinast to restore cardiovascular haemodynamics following inhibition of nitric oxide synthesis.

Authors:  N A Herity; J D Allen; B Silke; A A Adgey
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.